Skip to main content
SpringerLink
Log in

Experimental Study of Heart Functionality during Treatment of Chronic Heart Failure in Rats of Different Age Groups with Levosimendan (Experimental Study)

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Levosimendan is effective in the therapy of chronic heart failure in both mature and old rats, but the duration of its therapeutic effect differs in these age groups. In 15 days after treatment, the myocardium in old rats maintained augmented functionality, whereas in old animals, functional potencies returned to the levels observed prior to the therapy. Stimulation of tissue respiration with combined administration of L-carnitine and α-lipoic acid against the background of levosimendan treatment prolonged its therapeutic effect in mature, but not in old rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lushnikova EL, Nepomnyashchikh LM, Molodykh NA, Klinnikova MG, Molodykh OP. Structural reorganization of the rat myocardium and the number of cardiomyocytes under the action of doxorubicin and triterpenoids. Fundamental. Issled. 2011;(6):98-102. Russian.

    Google Scholar 

  2. Mamalyga ML, Mamalyga LM. Effect of Progressive Heart Failure on Cerebral Hemodynamics and Monoamine Metabolism in CNS. Bull. Exp. Biol. Med. 2017;163(3):307-312. doi: https://doi.org/10.1007/s10517-017-3791-1

    Article  CAS  PubMed  Google Scholar 

  3. Aliev G, Liu J, Shenk JC, Fischbach K, Pacheco GJ, Chen SG, Obrenovich ME, Ward WF, Richardson AG, Smith MA, Gasimov E, Perry G, Ames BN. Neuronal mitochondrial amelioration by feeding acetyl-L-carnitine and lipoic acid to aged rats. J. Cell. Mol. Med. 2009;13(2):320-333.

    Article  CAS  PubMed  Google Scholar 

  4. Bayeva M, Gheorghiade M, Ardehali H. Mitochondria as a therapeutic target in heart failure. J. Am. Coll. Cardiol. 2013; 61(6):600-610.

    Article  CAS  Google Scholar 

  5. Cusack BJ, Musser B, Gambliel H, Hadjokas NE, Olson RD. Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats. Cancer Chemother. Pharmacol. 2003;51(2):139-146.

    Article  CAS  PubMed  Google Scholar 

  6. du Toit EF, Genis A, Opie LH, Pollesello P, Lochner A. A role for the RISK pathway and K(ATP) channels in pre- and postconditioning induced by levosimendan in the isolated guinea pig heart. Br. J. Pharmacol. 2008;154(1):41-50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Feridooni HA, Kane A.E, Ayaz O, Boroumandi A, Polidovitch N, Tsushima RG, Rose RA, Howlett SE. The impact of age and frailty on ventricular structure and function in C57BL/6J mice. J. Physiol. 2017;595(12):3721-3742.

  8. Fleg JL, Strait J. Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev. 2012;17(4-5):545-554.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hagen TM, Moreau R, Suh JH, Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann. N.Y. Acad. Sci. 2002;959(1):491-507.

    Article  CAS  PubMed  Google Scholar 

  10. Kopustinskiene DM, Pollesello P, Saris NE. Potassium-specific effects of levosimendan on heart mitochondria. Biochem. Pharmacol. 2004;68(5):807-812.

    Article  CAS  PubMed  Google Scholar 

  11. Lesnefsky EJ, Moghaddas S, Tandler B, Kerner J, Hoppel CL. Mitochondrial dysfunction in cardiac disease: ischemia—reperfusion, aging, and heart failure. J. Mol. Cell. Cardiol. 2001;33(6):1065-1089.

    Article  CAS  PubMed  Google Scholar 

  12. Mamalyga ML. Cardiovascular Dysfunctions in Brain Disorders and Their Treatment. Saarbrücken, 2017.

    Google Scholar 

  13. Pollesello P, Papp Z. The cardioprotective effects of levosimendan: preclinical and clinical evidence. J. Cardiovasc. Pharmacol. 2007;50(3):257-263.

    Article  CAS  PubMed  Google Scholar 

  14. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, Voigt JU, Zamorano JL; European Association of Echocardiography. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur. J. Echocardiogr. 2008;9(4):415-437.

    Article  PubMed  Google Scholar 

  15. Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart Fail Clin. 2012;8(1):143-164.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anatomy and Physiology of Humans and Animals, Institute of Biology and Chemistry, Moscow State Pedagogical University, Moscow, Russia

    M. L. Mamalyga & L. M. Mamalyga

Authors
  1. M. L. Mamalyga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Mamalyga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. L. Mamalyga.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 169, No. 1, pp. 22-27, January, 2020

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mamalyga, M.L., Mamalyga, L.M. Experimental Study of Heart Functionality during Treatment of Chronic Heart Failure in Rats of Different Age Groups with Levosimendan (Experimental Study). Bull Exp Biol Med 169, 18–23 (2020). https://doi.org/10.1007/s10517-020-04815-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-020-04815-8

Key Words

Search

Navigation